Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
GE Healthcare Technologies Inc ( (GEHC) ) has shared an update.
On June 9, 2025, GE Healthcare Technologies Inc. issued $1.5 billion in senior notes, divided into $650 million due in 2031 and $850 million due in 2035. These senior unsecured notes are part of the company’s strategy to manage its debt portfolio and maintain its financial flexibility, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (GEHC) stock is a Buy with a $100.00 price target. To see the full list of analyst forecasts on GE Healthcare Technologies Inc stock, see the GEHC Stock Forecast page.
Spark’s Take on GEHC Stock
According to Spark, TipRanks’ AI Analyst, GEHC is a Outperform.
GE Healthcare Technologies Inc shows strong financial fundamentals and positive corporate actions, but faces challenges from tariff impacts and market conditions in China. Solid valuation metrics and successful product launches provide support, while technical analysis indicates a balanced outlook.
To see Spark’s full report on GEHC stock, click here.
More about GE Healthcare Technologies Inc
GE Healthcare Technologies Inc. operates in the healthcare industry, focusing on providing advanced medical technologies and services. The company is known for its innovative solutions in medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, catering to healthcare professionals and institutions worldwide.
Average Trading Volume: 4,892,974
Technical Sentiment Signal: Strong Sell
Current Market Cap: $32.79B
For detailed information about GEHC stock, go to TipRanks’ Stock Analysis page.